Acurx Pharmaceuticals (ACXP) vs Medicus Pharma (MDCX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Acurx Pharmaceuticals is the larger company by market cap ($7.1 million vs $138,068), about 51.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACXP | MDCX |
|---|---|---|
| Share price | $1.27 | $0.0921 |
| Market cap | $7.06M | $138.07K |
| 1-day change | +1.60% | -9.62% |
| YTD return | — | -93.34% |
| 1-year return | — | -95.86% |
| EPS (TTM) | $-2.67 | $-119.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.98 | $139.00 |
| 52-week low | $1.23 | $0.084 |
| Distance from 52-week high | -84.09% | -99.93% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +1238.58% | +4785.99% |
| Average volume | 125.08K | 92.96K |
| Shares outstanding | 5.56M | 1.50M |
| Employees | 4 | 16 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Acurx Pharmaceuticals is about 51.1 times larger than Medicus Pharma by market value ($7.06M vs $138.07K).
About Acurx Pharmaceuticals
ACXP stock →Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Medicus Pharma
MDCX stock →Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.
Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees
ACXP vs MDCX FAQ
Which is bigger, Acurx Pharmaceuticals or Medicus Pharma?
Acurx Pharmaceuticals (ACXP) is larger, with a market capitalization of $7.06M compared with $138.07K for Medicus Pharma (MDCX).
Are Acurx Pharmaceuticals and Medicus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.